Topical creams are becoming part of the mix of pain treatment options as doctors look for alternatives to addictive opioids.
On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).
Overall length of rental (LOR) for collision-related rentals in the U.S. in Q4 2023 was 17.7 days, a one-day decline from Q4 2022. In Q4 2022, LOR (18.7 days) was up one-half day from Q4 2021, so the trend of declining year-over-year LOR we’ve been tracking since Q2 2023 continues. Compared to Q4 2021, LOR is up 0.7 days.
A large national workers' comp carrier with provider reconciliation difficulties and administrative burdens needed a cost-saving alternative to expensive paper-based payment processes. The carrier wanted to streamline their payment experience and reduce manual processing and workload in their billing and accounts receivable department.
Coventry understands the value of maintaining accurate provider data; therefore, Coventry is taking aggressive action to ensure network data is current and accurate.
The healthcare sector is experiencing an expansion in digital health solutions at a rapid rate, marking a transformative period in medical technology and patient care.